BioCorteX
BioCorteX is a biotechnology company that focuses on drug development by studying the interactions between human microbiomes and therapeutics. Their platform is based on a biology-based knowledge graph and aims to create treatments for various populations with serious diseases.
- Carbon Mirror
- Carbon Knowledge
- Therapeutics tailored to individual microbiomes
Locations
Digital Popularity
Social Media
Competitors
Alchemab Therapeutics is dedicated to harnessing the power of the immune system to develop innovative antibody therapeutics for hard-to-treat diseases.
Prokarium is a biopharmaceutical company at the forefront of applying synthetic biology to create novel cancer treatments.
Company Details
BioCorteX is operated by Biocortex Ltd and is a Active company incorporated on 23 March 2021 with the registered office located in London, Greater London. Biocortex Ltd was registered 4 years ago.
Status
Active
Size
Small
Directors
5
Age
4 years old
Employees
13
Turnover
Unreported
Total Assets
£1.52M
Cash in Bank
£582.79K
Total Liabilities
-£107.79K
Teams
10
3
2
2
5
CEO & Co-founder • Joined Mar 2021
Non Executive Director • Joined Dec 2022
Chief Technology Officer • Joined Oct 2022
Director Of Technology • Joined Apr 2023
Microbiome Data Scientist • Joined Oct 2022
Data Scientist And Researcher • Joined Apr 2023
Senior Clinician Scientist • Joined Feb 2023
Data Scientist And Researcher • Joined Mar 2021
Data Scientist • Joined Oct 2022
Senior Clinician Scientist • Joined Jun 2023
CEO & Co-founder • Joined Mar 2021
Non Executive Director • Joined Dec 2022
Chief Technology Officer • Joined Oct 2022
CEO & Co-founder • Joined Mar 2021
Director Of Technology • Joined Apr 2023
Director Of Technology • Joined Apr 2023
Data Scientist • Joined Oct 2022
Microbiome Data Scientist • Joined Oct 2022
Data Scientist And Researcher • Joined Apr 2023
Senior Clinician Scientist • Joined Feb 2023
Data Scientist And Researcher • Joined Mar 2021
Senior Clinician Scientist • Joined Jun 2023